Search - tctmd.com

Displaying 641 - 660 of 1679

Sort: Relevancy | Date

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

News Daily News

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

April 04, 2019

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

TCTMD’s Top 10 Most Popular Stories for March 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

March 29, 2019

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

March 15, 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

March 14, 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

March 06, 2019

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

March 01, 2019

TCTMD’s Top 10 Most Popular Stories for February 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

March 01, 2019

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

March 01, 2019

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

News Daily News

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

February 25, 2019

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

February 20, 2019

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

February 19, 2019

Window for IV Thrombolysis in Stroke May Stay Open Twice as Long With Imaging Selection

News Conference News ISC 2019

Window for IV Thrombolysis in Stroke May Stay Open Twice as Long With Imaging Selection

February 14, 2019

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

February 13, 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

News Conference News ISC 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

February 11, 2019

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

News Daily News

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

February 08, 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

News Conference News ISC 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

February 08, 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

February 08, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.